Find-A-Study

Home
About
Research Areas
Researchers
Clinical Trials

UT Health San Antonio

Home
About
Research Areas
Researchers
Clinical Trials

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Contact The Study Team

To contact the study team, select:
Continue as Guest - to notify the team of your request without creating a profile.
Register - will allow you to create a profile that you can later reference and view all the studies you have inquired about.
Login - If you have already Registered, select Login.

Continue as Guest

Enter Your Contact Information

{{emailError}}

Comments

First Name

{{fNameError}}

Last Name

{{lNameError}}

Telephone #

Yes, I would like to be contacted about studies in the same category or cancer site

Privacy Notice: The data collected here will be used by UT Health San Antonio staff to contact you, either by email or by telephone, with the sole purpose of providing you with information regarding human study participation. You may be contacted in the future regarding studies similar to this one. Under no circumstances will we use your information for other purposes or share it with others. To the extent it is applicable, UT Health San Antonio complies with the General Data Protection Regulation (“GDPR”). Should you have any requests pertaining to your rights under the GDPR, please send it to: The IRB Reliance Team at irbreliance@uthscsa.edu | (210) 567-8555

Lay Description

This randomized phase III trial is studying different combination chemotherapy regimens and comparing how well they work in treating patients with newly diagnosed acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.

Eligibility

Eligible Ages: Between 1 Year and 9 Years
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact

Contact The Study Team

Continue as Guest

Enter Your Contact Information

{{emailError}}

Comments

First Name

{{fNameError}}

Last Name

{{lNameError}}

Telephone #

Yes, I would like to be contacted about studies in the same category or cancer site

Principal Investigator
Janice Marceaux

UT Health San Antonio

8403 Floyd Curl Dr
San Antonio, TX 78229

210-567-8555
IRBreliance@uthscsa.edu

Connect with us

Job Opportunities
Research Directory
Mission Magazine
Give a Donation

We're a part of the UT Health Science Center San Antonio, provider of comprehensive patient care, advanced academics, and life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Lay Description

Category

Eligibility

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact